Idorsia Makes Progress With Quviviq, But Needs Cash To Fund Big R&D And Launch Spending

CEO Loans Company $75m From Own Funds

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.